Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
RGC
vs
S&P 500
RGC
S&P 500
Over the past 12 months, RGC has underperformed S&P 500, delivering a return of -58% compared to S&P 500's +13% growth.
Stocks Performance
RGC vs S&P 500
Performance Gap
RGC vs S&P 500
Create a free account · No card needed
Performance By Year
RGC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Regencell Bioscience Holdings Ltd
Glance View
Regencell Bioscience Holdings is a small bioscience company focused on traditional Chinese medicine, especially formulas aimed at children with neurocognitive conditions such as autism and ADHD. Instead of making broad drug pipelines, it centers on a narrow set of TCM-based products and treatment approaches built around its own research and formulas. The company’s main customers are patients and families, usually through clinics or other healthcare channels that use its products or treatment programs. It makes money by selling these TCM formulas and related services, and its business depends on getting physicians, clinics, and caregivers to trust and use its approach. What makes the business model different is that it sits between healthcare and herbal medicine rather than conventional pharmaceuticals. That means the company’s value comes from its proprietary formulas, medical positioning, and ability to commercialize a niche treatment approach, not from large-scale drug manufacturing or broad consumer branding.
Create a free account · No card needed
